Evaluation and Treatment of Dyspareunia
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Dyspareunia: an Integrated Approach to Assessment and Diagnosis
PROBLEMS IN FAMILY PRACTICE Dyspareunia: An Integrated Approach to Assessment and Diagnosis Genell Sandberg, PhD, and Randal P. Quevillon, PhD Seattle, Washington, and Vermillion, South Dakota Dyspareunia, or painful intercourse, is frequently referred to as the most common female sexual dysfunction. It can occur singly or be manifested in combination with other psychosexual disorders. Diagnosis of dyspareunia is appropriate in cases in which the experience of pain is persistent and severe. There has been little agreement concerning the origin of dyspareunia. Or ganic conditions and psychological variables have alternately been pre sented as major factors in causality. There is a presumed high incidence of physical disease associated with dyspareunia when compared with other female sexual dysfunctions. In the majority of cases, however, organic fac tors are thought to be rare in contrast with sexual issues and interpersonal or intrapsychic difficulties as a cause of continuing problems. The finding of an organic basis for dyspareunia does not rule out emotional or psychogenic causes. Thorough and extensive gynecologic and psycholog ical evaluation is essential in cases of dyspareunia. The etiology of dys pareunia should be viewed on a continuum from primarily physical to primar ily psychological with many women falling in the middle area. recurrent pattern of genital pain during or im Dyspareunia and vaginismus are undeniably linked, A mediately after coitus is the basis for the diagnosis and repeated dyspareunia is likely to result in vaginis of dyspareunia.1 The Diagnostic and Statistical Man mus, as vaginismus may be the causative factor in ual of Mental Disorders (DSM-III)2 has included dys dyspareunia.6-7 The difference between vaginismus pareunia under the classification of psychosexual dis and dyspareunia is that intromission is generally pain orders. -
Adenomyosis in Infertile Women: Prevalence and the Role of 3D Ultrasound As a Marker of Severity of the Disease J
Puente et al. Reproductive Biology and Endocrinology (2016) 14:60 DOI 10.1186/s12958-016-0185-6 RESEARCH Open Access Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease J. M. Puente1*, A. Fabris1, J. Patel1, A. Patel1, M. Cerrillo1, A. Requena1 and J. A. Garcia-Velasco2* Abstract Background: Adenomyosis is linked to infertility, but the mechanisms behind this relationship are not clearly established. Similarly, the impact of adenomyosis on ART outcome is not fully understood. Our main objective was to use ultrasound imaging to investigate adenomyosis prevalence and severity in a population of infertile women, as well as specifically among women experiencing recurrent miscarriages (RM) or repeated implantation failure (RIF) in ART. Methods: Cross-sectional study conducted in 1015 patients undergoing ART from January 2009 to December 2013 and referred for 3D ultrasound to complete study prior to initiating an ART cycle, or after ≥3 IVF failures or ≥2 miscarriages at diagnostic imaging unit at university-affiliated private IVF unit. Adenomyosis was diagnosed in presence of globular uterine configuration, myometrial anterior-posterior asymmetry, heterogeneous myometrial echotexture, poor definition of the endometrial-myometrial interface (junction zone) or subendometrial cysts. Shape of endometrial cavity was classified in three categories: 1.-normal (triangular morphology); 2.- moderate distortion of the triangular aspect and 3.- “pseudo T-shaped” morphology. Results: The prevalence of adenomyosis was 24.4 % (n =248)[29.7%(94/316)inwomenaged≥40 y.o and 22 % (154/ 699) in women aged <40 y.o., p = 0.003)]. Its prevalence was higher in those cases of recurrent pregnancy loss [38.2 % (26/68) vs 22.3 % (172/769), p < 0.005] and previous ART failure [34.7 % (107/308) vs 24.4 % (248/1015), p < 0.0001]. -
Pelvic Inflammatory Disease (PID) PELVIC INFLAMMATORY DISEASE (PID)
Clinical Prevention Services Provincial STI Services 655 West 12th Avenue Vancouver, BC V5Z 4R4 Tel : 604.707.5600 Fax: 604.707.5604 www.bccdc.ca BCCDC Non-certified Practice Decision Support Tool Pelvic Inflammatory Disease (PID) PELVIC INFLAMMATORY DISEASE (PID) SCOPE RNs (including certified practice RNs) must refer to a physician (MD) or nurse practitioner (NP) for all clients who present with suspected PID as defined by pelvic tenderness and lower abdominal pain during the bimanual exam. ETIOLOGY Pelvic inflammatory disease (PID) is an infection of the upper genital tract that involves any combination of the uterus, endometrium, ovaries, fallopian tubes, pelvic peritoneum and adjacent tissues. PID consists of ascending infection from the lower-to-upper genital tract. Prompt diagnosis and treatment is essential to prevent long-term sequelae. Most cases of PID can be categorized as sexually transmitted and are associated with more than one organism or condition, including: Bacterial: Chlamydia trachomatis (CT) Neisseria gonorrhoeae (GC) Trichomonas vaginalis Mycoplasma genitalium bacterial vaginosis (BV)-related organisms (e.g., G. vaginalis) enteric bacteria (e.g., E. coli) (rare; more common in post-menopausal people) PID may be associated with no specific identifiable pathogen. EPIDEMIOLOGY PID is a significant public health problem. Up to 2/3 of cases go unrecognized, and under reporting is common. There are approximately 100,000 cases of symptomatic PID annually in Canada; however, PID is not a reportable infection so, exact -
3-Year Results of Transvaginal Cystocele Repair with Transobturator Four-Arm Mesh: a Prospective Study of 105 Patients
Arab Journal of Urology (2014) 12, 275–284 Arab Journal of Urology (Official Journal of the Arab Association of Urology) www.sciencedirect.com ORIGINAL ARTICLE 3-year results of transvaginal cystocele repair with transobturator four-arm mesh: A prospective study of 105 patients Moez Kdous *, Fethi Zhioua Department of Obstetrics and Gynecology, Aziza Othmana Hospital, Tunis, Tunisia Received 27 January 2014, Received in revised form 1 May 2014, Accepted 24 September 2014 Available online 11 November 2014 KEYWORDS Abstract Objectives: To evaluate the long-term efficacy and safety of transobtura- tor four-arm mesh for treating cystoceles. Genital prolapse; Patients and methods: In this prospective study, 105 patients had a cystocele cor- Cystocele; rected between January 2004 and December 2008. All patients had a symptomatic Transvaginal mesh; cystocele of stage P2 according to the Baden–Walker halfway stratification. We Polypropylene mesh used only the transobturator four-arm mesh kit (SurgimeshÒ, Aspide Medical, France). All surgical procedures were carried out by the same experienced surgeon. ABBREVIATIONS The patients’ characteristics and surgical variables were recorded prospectively. The VAS, visual analogue anatomical outcome, as measured by a physical examination and postoperative scale; stratification of prolapse, and functional outcome, as assessed by a questionnaire TOT, transobturator derived from the French equivalents of the Pelvic Floor Distress Inventory, Pelvic tape; Floor Impact Questionnaire and the Pelvic Organ Prolapse–Urinary Incontinence- TVT, tension-free Sexual Questionnaire, were considered as the primary outcome measures. Peri- vaginal tape; and postoperative complications constituted the secondary outcome measures. TAPF, tendinous arch Results: At 36 months after surgery the anatomical success rate (stage 0 or 1) was of the pelvic fascia; 93%. -
Dysmenorrhoea
[ Color index: Important | Notes| Extra | Video Case ] Editing file link Dysmenorrhoea Objectives: ➢ Define dysmenorrhea and distinguish primary from secondary dysmenorrhea ➢ • Describe the pathophysiology and identify the etiology ➢ • Discuss the steps in the evaluation and management options References : Hacker and moore, Kaplan 2018, 428 boklet ,433 , video case Done by: Omar Alqahtani Revised by: Khaled Al Jedia DYSMENORRHEA Definition: dysmenorrhea is a painful menstruation it could be primary or secondary Primary dysmenorrhea Definition: Primary dysmenorrhea refers to recurrent, crampy lower abdominal pain, along with nausea, vomiting, and diarrhea, that occurs during menstruation in the absence of pelvic pathology. It is the most common gynecologic complaint among adolescent girls. Characteristic: The onset of pain generally does not occur until ovulatory menstrual cycles are established. Maturation of the hypothalamic-pituitary-gonadal axis leading to ovulation occurs in half of the teenagers within 2 years post-menarche, and the majority of the remainder by 5 years post-menarche. (so mostly it’s occur 2-5 years after first menstrual period) • The symptoms typically begin several hours prior to the onset of menstruation and continue for 1 to 3 days. • The severity of the disorder can be categorized by a grading system based on the degree of menstrual pain, the presence of systemic symptoms, and impact on daily activities Pathophysiology Symptoms appear to be caused by excess production of endometrial prostaglandin F2α resulting from the spiral arteriolar constriction and necrosis that follow progesterone withdrawal as the corpus luteum involutes. The prostaglandins cause dysrhythmic uterine contractions, hypercontractility, and increased uterine muscle tone, leading to uterine ischemia. -
Vaginitis and Abnormal Vaginal Bleeding
UCSF Family Medicine Board Review 2013 Vaginitis and Abnormal • There are no relevant financial relationships with any commercial Vaginal Bleeding interests to disclose Michael Policar, MD, MPH Professor of Ob, Gyn, and Repro Sciences UCSF School of Medicine [email protected] Vulvovaginal Symptoms: CDC 2010: Trichomoniasis Differential Diagnosis Screening and Testing Category Condition • Screening indications – Infections Vaginal trichomoniasis (VT) HIV positive women: annually – Bacterial vaginosis (BV) Consider if “at risk”: new/multiple sex partners, history of STI, inconsistent condom use, sex work, IDU Vulvovaginal candidiasis (VVC) • Newer assays Skin Conditions Fungal vulvitis (candida, tinea) – Rapid antigen test: sensitivity, specificity vs. wet mount Contact dermatitis (irritant, allergic) – Aptima TMA T. vaginalis Analyte Specific Reagent (ASR) Vulvar dermatoses (LS, LP, LSC) • Other testing situations – Vulvar intraepithelial neoplasia (VIN) Suspect trich but NaCl slide neg culture or newer assays – Psychogenic Physiologic, psychogenic Pap with trich confirm if low risk • Consider retesting 3 months after treatment Trichomoniasis: Laboratory Tests CDC 2010: Vaginal Trichomoniasis Treatment Test Sensitivity Specificity Cost Comment Aptima TMA +4 (98%) +3 (98%) $$$ NAAT (like GC/Ct) • Recommended regimen Culture +3 (83%) +4 (100%) $$$ Not in most labs – Metronidazole 2 grams PO single dose Point of care – Tinidazole 2 grams PO single dose •Affirm VP III +3 +4 $$$ DNA probe • Alternative regimen (preferred for HIV infected -
The Vulva Vaginal Diseases in Daily Practice Layout 1
Experimental & Clinical Article Gynecology; and Gynecologial Onncology The Vulva / Vaginal Diseases in Daily Practice Gamze S. ÇAĞLAR1, Elif D. ÖZDEMİR1, Sevim D. CENGİZ1, Handan DOĞAN2 Ankara, Turkey OBJECTIVE: To emphasize the neglected vulva/vaginal lesions and symptoms commonly encountered in daily practice. STUDY DESIGN: The data of 98 patients with vulva or vaginal biopsies were collected retrospectively. The histopathological diagnosis of 82(83.67%) vulvar and 16(16.32%) vaginal biopsy cases were eval- uated. RESULTS: The most common symptom was mass in 67% and 62% of cases in vulvar and vaginal re- gion, respectively. Among the vulvar lesions the most frequent histopathological diagnoses were condy- loma acuminatum (20.73%), hyperkeratotic papilloma (14.63%), non-spesific inflammatory changes (12.19%), fibroepithelial polyp (9.75%) and bartholin cyst (8.53%). On the other hand, the histopatolog- ical evaluation of the vaginal lesions revealed vaginal stromal polyp (25%) and gartner cyst (25%) as the most frequent lesions. CONCLUSIONS: The results of the study document lesions commonly not well known or disregarded by gynecologists. The literature is inconclusive about vulvavaginal diseases. Expanded data will help the clinicians in making correct diagnoses and patient managament. Key Words: Fibroepithelial polyp, Hyperkeratotic papilloma, Stromal polyp, Vaginal diseases, Vulvar diseases. Gynecol Obstet Reprod Med 2011;17:155-159 Introduction The clinicians should be aware of these physiological changes that will help in guiding the vulvar/vaginal symptoms Vulva is once called forgetten pelvic organ and related and disorders in daily clinical practice. There is limited data symptoms are usually considered as unimportant.1 The most about the most common reported histopathological diagnoses common compliants in women admitting to gynecology clin- and management in vulvavaginal diseases. -
An Unusual Cause of Chronic Low Back Pain
Yunus Durmaz et al. / International Journal Of Advances In Case Reports, 2015;2(23):1425-1426. e - ISSN - 2349 - 8005 INTERNATIONAL JOURNAL OF ADVANCES IN CASE REPORTS Journal homepage: www.mcmed.us/journal/ijacr RETROVERTED UTERUS: AN UNUSUAL CAUSE OF CHRONIC LOW BACK PAIN Yunus Durmaz1, Ilker Ilhanli2*, Kıvanc Cengiz3 1Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Mehmet Akif Inan Training and Research Hospital, Sanlıurfa, Turkey. 2Department of Physical Medicine and Rehabilitation, School of Medicine, University of Giresun, Giresun, Turkey. 3Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Sivas Numune Hospital, Sivas, Turkey. Corresponding Author:- Ilker ILHANLI E-mail: [email protected] Article Info ABSTRACT Received 15/09/2015 Retroverted uterus can be associated with chronic low back pain. Physicians should keep in mind this Revised 27/10/2015 cause of chronic low back pain for the premenopausal women. Here we presented two female patients Accepted 2/11/2015 at the ages of 21 and 28; they were diagnosed as retroverted uterus by Magnetic Resonance Imaging with any other cause of chronic low back pain. Key words: Retroverted uterus; Low back pain; Magnetic resonance imaging. INTRODUCTION Retrovertion is an anatomical variation of the too. She reported any trauma or family history of uterus which can be associated with low back pain, as well spondyloarthropathy. There was no radiculopathy sign or as the chronic pelvic pain. Also it can cause congestive muscle spasm. She didn’t meet the criteria of fibromyalgia. dysmenorrhea, deep dyspareunia, and bladder and bowel Lomber Schober test was normal. Straight leg raising, symptoms [1]. -
Management of Uterine Prolapse: Is Hysterectomy Necessary?
DOI: 10.1111/tog.12220 2016;18:17–23 Review The Obstetrician & Gynaecologist http://onlinetog.org Management of uterine prolapse: is hysterectomy necessary? a b b, Helen Jefferis MRCOG, Simon Robert Jackson MD FRCOG, Natalia Price MD MRCOG * aSubspeciality Trainee in Urogynaecology, Department of Urogynaecology, Women’s Centre, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK bConsultant Urogynaecologist, Department of Urogynaecology, Women’s Centre, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK *Correspondence: Natalia Price. Email: [email protected] Accepted on 1 June 2015 Key content Fertility preservation remains the one absolute indication for Management of uterine prolapse is currently heavily influenced by hysteropexy. Other potential advantages include stronger apical patient and surgeon preferences. support and reduced vaginal surgery. The traditional approach to uterine prolapse is vaginal Colpocleisis remains a valid option for a small cohort of patients. hysterectomy. However, this does not address the underlying Learning objectives deficiency in connective tissue pelvic floor support, and prolapse Options for the management of uterine prolapse. recurrence is common. How to help patients decide on a management plan. Uterine preservation surgery is increasing in popularity, both with surgeons and patients; there is currently little evidence to show Keywords: colpocleisis / hysteropexy / pelvic organ prolapse / superior outcome to hysterectomy. uterine preservation surgery / vaginal hysterectomy Please cite this paper as: Jefferis H, Jackson SR, Price N. Management of uterine prolapse: is hysterectomy necessary? The Obstetrician & Gynaecologist 2016;18: 17–23. DOI: 10.1111/tog.12220 Introduction significantly associated with regression of prolapse, leading the authors to suggest that the damage obesity causes to the When a woman presents with pelvic organ prolapse, the pelvic floor may be irreversible. -
Sexually Transmitted Infections DST-1007 Mucopurulent Cervicitis (MPC)
Certified Practice Area: Reproductive Health: Sexually Transmitted Infections DST-1007 Mucopurulent Cervicitis (MPC) DST-1007 Mucopurulent Cervicitis (MPC) DEFINITION Inflammation of the cervix with mucopurulent or purulent discharge from the cervical os. POTENTIAL CAUSES Bacterial: • Chlamydia trachomatis (CT) • Neisserria gonorrhoeae (GC) Viral: • herpes simplex virus (HSV) Protozoan: • Trichomonas vaginalis (TV) Non-STI: • chemical irritants • vaginal douching • persistent disruption of vaginal flora PREDISPOSING RISK FACTORS • sexual contact where there is transmission through the exchange of body fluids • sexual contact with at least one partner • sexual contact with someone with confirmed positive laboratory test for STI • incomplete STI medication treatment • previous STI TYPICAL FINDINGS Sexual Health History • may be asymptomatic • sexual contact with at least one partner • increased abnormal vaginal discharge • dyspareunia • bleeding after sex or between menstrual cycles • external or internal genital lesions may be present with HSV infection • sexual contact with someone with confirmed positive laboratory test for STI Physical Assessment Cardinal Signs • mucopurulent discharge from the cervical os (thick yellow or green pus) and /or friability of the cervix (sustained bleeding after swabbing gently) BCCNM-certified nurses (RN(C)s) are responsible for ensuring they reference the most current DSTs, exercise independent clinical judgment and use evidence to support competent, ethical care. NNPBC January 2021. For more information or to provide feedback on this or any other decision support tool, email mailto:[email protected] Certified Practice Area: Reproductive Health: Sexually Transmitted Infections DST-1007 Mucopurulent Cervicitis (MPC) The following may also be present: • abnormal change in vaginal discharge • cervical erythema/edema Other Signs • cervicitis associated with HSV infection: o cervical lesions usually present o may have external genital lesions with swollen inguinal nodes Notes: 1. -
Pelvic Organ Prolapse
Quality ID #429: Pelvic Organ Prolapse: Preoperative Screening for Uterine Malignancy – National Quality Strategy Domain: Patient Safety – Meaningful Measure Area: Preventable Healthcare Harm 2019 COLLECTION TYPE: MEDICARE PART B CLAIMS MEASURE TYPE: Process – High Priority DESCRIPTION: Percentage of patients who are screened for uterine malignancy prior to vaginal closure or obliterative surgery for pelvic organ prolapse INSTRUCTIONS: This measure is to be submitted each time a prolapse organ repair surgery is performed during the performance period. There is no diagnosis associated with this measure. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding. Measure Submission Type: Measure data may be submitted by individual MIPS eligible clinicians using Medicare Part B claims. The listed denominator criteria are used to identify the intended patient population. The numerator quality-data codes included in this specification are used to submit the quality actions allowed by the measure on the claim form(s). All measure- specific coding should be submitted on the claim(s) representing the denominator eligible encounter and selected numerator option. DENOMINATOR: All patients undergoing surgery for pelvic organ prolapse involving vaginal closure/obliterative procedure Denominator Criteria (Eligible Cases): All patients, regardless of age AND Patient procedure during -
Histopathology Findings of the Pelvic Organ Prolapse
Review Histopathology fndings of the pelvic organ prolapse FERNANDA M.A. CORPAS1, ANDRES ILLARRAMENDI2, FERNANDA NOZAR3, BENEDICTA CASERTA4 1 Asistente Clínica Ginecotocológica A CHPR, 2 Residente de Ginecología, Clínica Ginecotocológica A CHPR, 3 Profesora Adjunta Clínica Ginecotocológica A CHPR, 4 Jefa del servicio de Anatomía Patológica del CHPR, Presidenta de la Sociedad de Anatomía Patológica del Uruguay, Centro Hospitalario Pereira Rossell (Chpr), Montevideo, Uruguay Abstract: Pelvic organ prolapse is a benign condition, which is the result of a weakening of the different components that provide suspension to the pelvic foor. Surgical treatment, traditionally involve a vaginal hysterectomy, although over the last few decades the preservation of the uterus has become more popular. The objective of the paper is to analyze the characteristics of those patients diagnosed with pelvic organ prolapse, whose treatment involved a vaginal hysterectomy and its correlation to the histopathological characteristics. Retrospective, descriptive study. Data recovered from the medical history of patients that underwent surgical treatment for pelvic organ prolapse through vaginal hysterectomy, were analyzed in a 2 years period, in the CHPR, and compared to the pathology results of the uterus. At the level of the cervix, 58,2% presented changes related to the prolapse (acantosis, para and hyperqueratosis) and 43,6% chronic endocervicitis. Findings in the corpus of the uterus were 58,2% atrophy of the endometrium, 21% of endometrial polyps and 30.9% leiomiomas and 1 case of simple hyperplasia without cellular atypias. No malignant lesions were found. The pathology results of the uterus reveal the presence of anatomical changes related to the pelvic organ prolapse and in accordance to the age of the patient, as well as associated pathologies to a lesser extent.